Sequent Scientific gets WHO - GENEVA’s approval for API Praziquantel

12 Mar 2020 Evaluate

Sequent Scientific, which has businesses across Animal Health (Alivira) & Analytical Services, has received WHO - GENEVA’s approval for active pharmaceutical ingredients (API) Praziquantel (Anthelmintic) under pre-qualification program. Alivira's Vizag site is India's only U.S. Food and Drug Administration (USFDA)-authorized and EU GMP-compliant facility focused on production of (APIs) for the animal health sector.

The Vizag site is a multipurpose manufacturing facility equipped with reactor capacity of 225KL and six clean rooms. The site began commercial production in 2015 and has been successfully inspected by USFDA during 2016 and 2018. This approval further emphasizes focus on compliance standards.

Sequent Scientific is an integrated pharmaceutical company with a global footprint headquartered in Bangalore, India which has presence in different pharmaceutical verticals including APIs, Animal Health, Analytical Services, CRAMS and specialty chemicals.

Sequent Scientific Share Price

199.65 -8.00 (-3.85%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×